company background image
SPPI

Spectrum Pharmaceuticals NasdaqCM:SPPI Stock Report

Last Price

US$1.03

Market Cap

US$209.9m

7D

5.3%

1Y

17.0%

Updated

02 Aug, 2023

Data

Company Financials +

Spectrum Pharmaceuticals, Inc.

NasdaqCM:SPPI Stock Report

Mkt Cap: US$209.9m

SPPI Stock Overview

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

SPPI fundamental analysis
Snowflake Score
Valuation6/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Spectrum Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Spectrum Pharmaceuticals
Historical stock prices
Current Share PriceUS$1.03
52 Week HighUS$1.57
52 Week LowUS$0.32
Beta2.14
1 Month Change4.54%
3 Month Change-1.90%
1 Year Change17.05%
3 Year Change-71.39%
5 Year Change-95.10%
Change since IPO-99.25%

Recent News & Updates

Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

May 14
Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

Recent updates

Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

May 14
Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates

May 12
Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates

Spectrum plunges 28% after FDA scientists question poziotinib evidence for NSCLC

Sep 20

Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?

Sep 16
Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?

Spectrum Pharmaceuticals stock jumps 10% afterhours on FDA nod for Rolvedon injection

Sep 09

Spectrum Pharmaceuticals: Revisiting This 'Soap Opera'

Aug 21

Spectrum Pharmaceuticals Q2 2022 Earnings Preview

Aug 10

Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Jun 04
Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Spectrum Pharmaceuticals: Some Last Words

Feb 25

Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Oct 05
Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity

Aug 12

Spectrum's Big Approval: Any Day Now

Jul 29

FDA initiates pre-approval inspection for Spectrum pharmaceuticals' ROLONTIS

Jun 01

Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

May 31
Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate

Feb 12
We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate

Spectrum Pharma drops after announcing less-than-favorable Phase 2 data

Dec 22

Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like

Dec 21
Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like

Spectrum Pharma Is Down But Not Out

Nov 16

Spectrum Shareholders In Limbo As FDA Delays Rolontis Decision Date, Agrees To Discuss Poziotinib

Nov 11

Shareholder Returns

SPPIUS BiotechsUS Market
7D5.3%-0.3%-2.7%
1Y17.0%7.5%13.1%

Return vs Industry: SPPI exceeded the US Biotechs industry which returned 8.6% over the past year.

Return vs Market: SPPI exceeded the US Market which returned 10.4% over the past year.

Price Volatility

Is SPPI's price volatile compared to industry and market?
SPPI volatility
SPPI Average Weekly Movement7.2%
Biotechs Industry Average Movement9.0%
Market Average Movement5.5%
10% most volatile stocks in US Market14.2%
10% least volatile stocks in US Market2.5%

Stable Share Price: SPPI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: SPPI's weekly volatility has decreased from 15% to 7% over the past year.

About the Company

FoundedEmployeesCEOWebsite
198786Tom Rigahttps://www.sppirx.com

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products. It offers ROLVEDON(Eflapegrastim), a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. The company develops Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations.

Spectrum Pharmaceuticals, Inc. Fundamentals Summary

How do Spectrum Pharmaceuticals's earnings and revenue compare to its market cap?
SPPI fundamental statistics
Market CapUS$209.89m
Earnings (TTM)-US$67.71m
Revenue (TTM)US$25.73m

8.2x

P/S Ratio

-3.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SPPI income statement (TTM)
RevenueUS$25.73m
Cost of RevenueUS$2.86m
Gross ProfitUS$22.87m
Other ExpensesUS$90.58m
Earnings-US$67.71m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.33
Gross Margin88.90%
Net Profit Margin-263.16%
Debt/Equity Ratio107.6%

How did SPPI perform over the long term?

See historical performance and comparison